1. Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy;
2. Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA;
3. Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;
4. Department of Hematology, Jewish General Hospital, Montreal, QC, Canada;
5. Hematology-Oncology, Hôpital Saint-Louis, Paris, France;
6. Division of Cancer Sciences, The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom;
7. DITEP, Insitut Gustave Roussy, Villejuif, France;
8. Immunology, Genetics and Pathology, Section of Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden;
9. Hematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece;
10. Hematology and Oncology, Fujita Health University School of Medicine, Toyoake, Japan;
11. Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Cologne, Germany;
12. Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, MA, USA;
13. Medical Oncology, Merck & Co., Inc, Kenilworth, NJ, USA;
14. Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA